Key facts
- It has raised $650K; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Tech Incubator Program for Startup, Smilegate Investment, Korea Investment Accelerator, COMEUP STARS, Digital Healthcare Partners — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for JamJam Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for JamJam Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About JamJam Therapeutics
Developer of a rehabilitation software designed for children with slow development. The company's game is designed so that disabled children can enjoy rehabilitation exercises at home without any special equipment, enabling users to experience the effects of the game and reduce the burden of rehabilitation.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2023
- Employees
- 14
- Website
- albaam.com/
- Ownership
- Privately Held (backing)
JamJam Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JamJam Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JamJam Therapeutics in its N-PORT filings yet. We sweep new filings monthly.